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Abstract
Background: To investigate perinatal decision-making and the use of obstetric interventions, we examined the
effects of antenatal steroids, tocolysis, and delivery mode on birth in a good condition (defined as presence of an
infant heart rate >100 at five minutes of age) and delivery-room (DR) death in extremely preterm deliveries.
Methods: Prospective cohort of all singleton births in England in 2006 at 22–26 weeks of gestation where the fetus
was alive at the start of labour monitoring or decision to perform caesarean section. Odds ratios adjusted for potential
confounders (aOR) were calculated using logistic regression.
Results: One thousand seven hundred twenty two singleton pregnancies were included. 1231 women received
antenatal steroids, 437 tocolysis and 356 delivered by Caesarean section. In babies born vaginally, aOR between a
partial course of steroids and improved condition at birth was 1.84, 95% CI: 1.20 to 2.82 and, for a complete course,
1.63, 95% CI: 1.08 to 2.47; for DR death, aORs were 0.34 (0.21 to 0.55) and 0.41 (0.26 to 0.64) for partial and complete
courses of steroids. No association was seen for steroid use in babies delivered by Caesarean section. Tocolysis was
associated with improved condition at birth (aOR 1.45, 95% CI: 1.05 to 2.0) and lower odds of death (aOR 0.48, 95% CI:
0.32 to 0.73). In women without spontaneous labour, Caesarean delivery at ≤ 24 and 25 weeks was associated with
improved condition at birth ((aORs 12.67 (2.79 to 57.60) and 4.94 (1.44 to 16.90), respectively) and lower odds of DR
death (aORs 0.03 (0.01 to 0.21) and 0.13 (0.03 to 0.55)). There were no differences at 26 weeks gestation or in women
with spontaneous labour.
Conclusions: Antenatal steroids are strongly associated with improved outcomes in babies born vaginally. Tocolysis
was associated with improvements in all analyses. Effects persisted after adjustment for perinatal decision-making.
However, associations between delivery mode and birth outcomes may be attributable to case selection.
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Background
Any perinatal intervention at extremely preterm gesta-
tions may have significant impact on long term health
of surviving children. There is often uncertainty over the
use of antenatal steroid, tocolysis or mode and timing
of delivery due to a paucity of evidence in this popula-
tion. In certain clinical situations, delaying delivery may
be particularly beneficial at such low gestational ages,
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although emergency Caesarean section may be the only
way to prevent stillbirth. There is anxiety that a poten-
tially hostile in utero environment may have an imme-
diate or subsequent adverse impact, and any potential
benefit of delaying delivery needs to be set against the
risk of complications associated with adverse perinatal
outcomes [1].
EPICure 2 is a whole population study of extremely
preterm births to women resident in England in 2006.
Short and long term outcomes have been reported else-
where [2, 3]. Compared with the original EPICure study
in 1995 for births 22–25 weeks, [4] a 13% improvement
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in survival was demonstrated, but no improvement in
the frequencies of major morbidities found [2]. Addition-
ally, evaluation of risk factors at birth in those admitted
to neonatal units in 1995 identified the baby born after
use of antenatal steroids whose heart rate was greater
than 100 beats per minute (bpm) at 5 min after birth
as more likely to survive and to have less long term
morbidity [4, 5].
In the 2006 cohort, background data were collected
about the pregnancy, obstetric management and any ante-
natal counselling, and overall outcome for all births. This
was done a priori to determine how antenatal compli-
cations, perinatal decision-making and management in
labour influence condition at birth in those born before
27 completed weeks gestational age [5]. For babies born
alive and admitted to neonatal intensive care, further data
were then collected about their condition, treatment and
outcome at discharge.
We evaluated the relationship of three specific peri-
natal interventions – antenatal steroids, tocolysis and
delivery by Caesarean section – to the chances of the
baby being born in a good condition and to death in
the delivery-room (DR). These outcomes may both be
attributed directly to obstetric care, rather than the com-
bined obstetric-neonatal input reflected in longer-term
outcomes. We specifically sought to assess whether peri-
natal decision-making is solely responsible for improved
short-term outcome, or whether there were addi-
tional, independent benefits conveyed by these obstetric
interventions.
Methods
Methods of case identification, data capture and other
design aspects used in this study have been described pre-
viously [2]. All births in English hospitals between 22 and
26 competed weeks of gestation (i.e. 26 weeks and 6 days
or less) occurring in 2006 to mothers normally resident
in England were included. Data collection was in collab-
oration with the Centre for Maternal and Child Health
Enquiries.
For the present study, the population was restricted to
mothers with singleton pregnancies where the fetus was
considered to be alive at admission to hospital and at
either the start of monitoring of the labour or the point at
which it was decided to perform Caesarean section. Ter-
minations of pregnancy were excluded. Birth in a good
condition was defined by the presence of a heart rate
above 100 bpm at 5 min after birth, whereas “delivery-
room death” includes all deaths during labour or in the
delivery room.
The data were subject to a detailed exploratory analy-
sis to investigate relationships between the different fac-
tors available, and also with the outcomes. In order to
assess the individual effect of different exposures, it is
necessary to examine each one separately, taking into
consideration the effects of potential confounding vari-
ables as well as accounting for any random variation.
Interpretation of results must then include the potential
impact of any biases that may be present. Consequently,
for this study, three factors were considered a priori as
exposures: administration of antenatal steroids, use of
tocolysis and Caesarean delivery.
Study variables
Data items available to describe antenatal condition were:
demographic data such as maternal age, ethnicity, body
size and smoking status; maternal medical complications
(diabetes either before or during pregnancy, hypertension
or epilepsy); obstetric complications (prolonged prema-
ture rupture of membranes, abruption, antepartum haem-
orrhage after 20 weeks of gestation, pre-eclampsia or
cervical incompetence warranting placement of a cervi-
cal suture); and fetal complications (intrauterine growth
restriction and/or oligohydramnios).
Gestational age of the infant, determined by the ear-
liest available ultrasound scan, was included as a cat-
egorical variable (per week) in the statistical analyses
for ease of presentation. Fetal sex was considered in all
analyses. Binary variables were created for labour type
(spontaneous or none/induced), mode of delivery (vagi-
nal or Caesarean) and presentation of the baby at delivery
(cephalic or non-cephalic). The presence or suspicion of
chorioamnionitis at any time was included as an ante-
natal risk factor, with maternal antibiotic administration
prior to labour classified into treatment, prophylaxis or
not prescribed. Administration of antenatal steroids was
categorised into three levels – none, partial course (if a
patient received the last dose less than 24 h prior to deliv-
ery), and full course (if the time interval to delivery was
greater than one day). Tocolysis, although initially anal-
ysed by type of drug administered, was re-categorised in a
binary fashion due to inadequate spread of data.
Provision of antenatal counselling was divided into the
actual provision (Was there counselling by a senior obste-
trician? Was there paediatric counselling?) and the con-
tent of the discussion. This included whether a decision
to not perform Caesarean section in cases of fetal dis-
tress was made; whether or not withholding care was
discussed; and whether the parents expressed any choice
about resuscitation and provision of neonatal intensive
care (provide full care for any live birth, withhold intensive
care, or assess and provide care at paediatric discretion; or
no choice expressed).
Health service factors were restricted to whether the
mother had been transferred antenatally, and the level of
neonatal care available at the delivering hospital. Mater-
nal socio-economic status was based upon the Index
of Multiple Deprivation 2007, using main residential
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postcode at the time of delivery. All data were col-
lected contemporaneously with the birth onto paper
forms and returned to a central office. Missing data
were followed-up by contacting the reporting hospital
until the data had been obtained, hence there are very
few data missing. Ethical approval was granted by East
London and City Research Ethics Committee (reference
05/Q0605/107) and permission was granted by the Patient
Information Advisory Group (reference 3–07(f )/2005)
to collect data without explicit consent, in conjunction
with routine data collection performed for CEMACH
(Confidential Enquiry into Maternal and Child Health)
purposes.
Statistical methods
Variables were categorised into fixed or background, preg-
nancy, obstetric clinical management, counselling and
delivery related factors. Data within and between dif-
ferent groups were cross-tabulated to explore relation-
ships; this aided the construction of diagrams of potential
causal pathways. In turn, these facilitated identification
of confounding variables and enabled selection of differ-
ent sub-populations for sensitivity analyses. Each of the
six exposure-outcome pairs was then investigated in a
separate analysis, with remaining variables considered as
potential confounders. All investigations were conducted
using R [6].
For each analysis, the unadjusted odds ratio (OR) of the
exposure on the outcome was calculated, followed by the
OR for each potential confounding variable in associa-
tion with both the exposure and the outcome. Univari-
able analysis was performed using the Mantel-Haenszel
approach (or univariable logistic regression if the expo-
sure had greater than one level) to determine which
factors had an important effect. Evidence for effect modi-
fication by variables was assessed using a chi-squared test
for homogeneity or likelihood ratio test (LRT) for each
method, respectively; for this, a p-value of < 0.1 was
accepted. Next, multivariable analysis was employed using
logistic regression with a forward step-wise approach, fol-
lowed by assessment for interaction terms. AWald test for
association was used to assess the adjusted effect of indi-
vidual factors on the outcome, with the LRT used to assess
the relative importance between nested models. The sig-
nificance level was set at p< 0.05. Models were developed
such that all biological/clinical variables were included
prior to variables related to antenatal counselling.
The impact of missing data was accounted for in two
ways. First, incomplete counselling data were recoded
to show whether a response was recorded or not; the
new variable was used to facilitate comparison with the
whole data set. Secondly, we performed sensitivity anal-
yses using two populations: for the steroid analyses,
all patients for whom there was evidence of having
received counselling, and for the tocolysis and mode
of delivery analyses, the population that had received
steroids.
Results
Population
In England during 2006, 2,466 singleton pregnancies were
delivered between 22+0 and 26+6 weeks gestation; 532
fetal deaths occurred prior to maternal admission to hos-
pital, 159 were alive at admission but died prior to the
onset of monitoring during labour, and for 53 timing of
death was unclear. Thus 1,722 women with a fetus known
to be alive both at admission to hospital and at commence-
ment of labour monitoring were included (Additional
file 1: Figure S1). 1395 women received some form of
medical treatment – including antibiotics, tocolysis, ante-
natal steroids and in utero transfer; of these, 1,278 were
also recorded as having received counselling (Fig. 1), 1,213
Fig. 1 Principal pathways in the obstetric antecedents analysis. Flow
diagram showing inclusion numbers, main pathways and principal
outcomes for an assessment of the impact of obstetric interventions
on condition at birth and delivery room death in the EPICure 2 cohort
of babies born between 22 and 26 completed weeks gestation in
England in 2006
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women received steroids and 437 tocolysis, but only 406
women received both, meaning that there were 31 women
who received tocolysis without receiving steroids as well
(Additional file 2: Figure S3).
Data items were more than 95% complete for all but
gestational age at booking (90.1%), maternal body mass
index (86.0%), parity (45.0%) and counselling. Of the five
items relating to counselling, 1,495 responses provided
some indication that counselling had occurred, includ-
ing 351 cases where a decision was made not to perform
emergency Caesarean section in cases of fetal distress,
465 women with whom withholding care was discussed
and 727 who expressed a choice regarding provision of
resuscitation to and intensive care to a live born baby;
additionally, 1,287 women were counselled by a senior
obstetrician and 1,246 by a paediatrician (Additional file 1:
Figure S2).
Four hundred and eighty-four (28.1%) babies died dur-
ing labour or in the delivery room, 28 of whom were in a
good condition at five minutes of age; overall, 600 (34.8%)
babies had a heart rate below 100 beats per minute five
minutes after delivery (Additional file 1: Figure S4). Each
of the three exposures was associated with birth in good
condition: unadjusted odds ratio (OR) for a partial course
of antenatal steroids was 5.08 (95% confidence interval
(CI): 3.84 – 6.72); for a full course 7.24 (95% CI: 5.60 – 9.36
with strong evidence of a trend (Chi-squared test for trend
p < 0.001); OR for tocolysis was 2.24 (95% CI: 1.75 – 2.90)
and for delivery by Caesarean section 4.21 (95% CI: 3.06
– 5.80). Each exposure was also associated with lowered
unadjusted odds of delivery-room death (partial course
of steroids: 0.13, 95% CI: 0.10 – 0.18; full course: 0.09,
95% CI: 0.07 – 0.12; tocolysis: 0.33, 95% CI: 0.24 – 0.44;
Caesarean delivery: 0.16, 95% CI: 0.10 – 0.24).
Univariate associations are shown in Additional file 2:
Table S1. Both gestational age (in weeks) and male sex
were strongly associated with condition at birth and
delivery-room death. Both outcomes were associated
with placental abruption, pre-eclampsia, in utero transfer,
spontaneous labour, non-cephalic presentation and deliv-
ery in a centre with a level 3 neonatal intensive care unit.
There were also strong associations between counselling
variables and both outcomes.
In the population that had evidence of receiving coun-
selling, the use of antenatal steroids was more frequent
than in the overall population (Table 1). There was no
difference in the use of tocolysis or surgical delivery, how-
ever, nor in fetal sex, gestational age profile or either
of the outcomes. In contrast, steroid-receiving mothers
were more frequently treated with tocolysis (33.47% com-
pared with 25.41% in the overall population, χ2 p-value <
0.01) or delivered by Caesarean section (25.72% v. 20.73%,
p < 0.01), and there was a shift towards higher gestational
age at delivery. There were no differences in terms of fetal
sex or in the decision to not perform Caesarean section
in the presence of fetal distress among steroid-treated
mothers.
Antenatal steroids
Gestational age had the largest impact on the relation-
ship between antenatal steroids and both outcomes. For
condition at birth, gestational age reduced the ORs to
2.09 (95% CI: 1.51 – 2.90) and 2.53 (95% CI: 1.85 – 3.45)
for partial and complete courses of steroids, respectively
(Table 2) and, for delivery room death, the ORs were 0.39
(95% CI: 0.27 – 0.56) for partial and 0.35 (95% CI: 0.25
– 0.50) for a full course of steroids (Table 3). Gestational
age was therefore included as the first potential clinical
confounder in the multivariable analysis, followed by (in
order) use of tocolysis, mode of delivery, NICU level at
birth, in utero transfer, presence of spontaneous labour,
and presentation at birth.Who the woman was counselled
by, whether withholding care was discussed or the par-
ents expressed a choice regarding resuscitation options,
and the decision whether to perform Caesarean in case
of fetal distress were included as potential counselling
confounders. Additionally, there was evidence of effect
modification by mode of delivery (LRT p < 0.001 in the
univariate analysis for condition at birth, p = 0.008 for
delivery room death) – but not from any other factors –
hence this was entered into the model last.
All clinical confounders except spontaneous/induced
labour contributed to the final model for birth in good
condition (adjusted ORs (aOR) for a partial course 1.42
(95% CI: 0.99 – 2.04); complete course: 1.64 (95% CI: 1.16
– 2.35). The only counselling variable not affecting the
final model related to whether or not withholding care
was discussed. Even after the other counselling variables
were included, a complete course of steroids retained a
strong effect (aOR of 1.82 (95% CI: 1.22 – 2.71)). Almost
the same factors were influential on the odds of delivery
room death, except for delivery presentation which had
no effect and presence of a spontaneous labour which did.
Results adjusted for clinical variables show a change in
the odds ratio to 0.47 (95% CI: 0.32 – 0.70) for a partial
course and 0.45 (95% CI: 0.30 – 0.67) for a full course of
steroids. After adjustment for counselling factors, the ORs
were 0.47 (95% CI: 0.31 – 0.73) and 0.37 (95% CI: 0.23 -
0.58) for partial and full courses, respectively.
When taking into account the potential interaction with
mode of delivery, there was no evidence of birth in an
improved condition after administration of steroids ante-
natally for those babies born by Caesarean section, but a
strong benefit to babies born vaginally (LRT p = 0.018).
Those who received a partial course of steroids demon-
strated an improved odds ratio of 1.61 (95% CI: 1.09 -
2.37) which increased further to 1.84 (95% CI: 1.20 – 2.82)
after the inclusion of counselling variables, as shown in
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Table 1 Characteristics of key variables for the different study populations used in the obstetric antecedents investigation
Variable
“Complete” population ‘Counselled’ population “Steroids only” population
N % N % P-valuea N % P-valueb
Antenatal steroids 1701 — 1484 — — 1213 — —
None 488 28.69 358 24.12
0.01
0 0.00
< 0.01Partial 452 26.57 400 26.95 452 37.26
Full 761 44.74 726 48.92 761 62.74
Tocolysis 1720 — 1495 — — 1213 — —
No 1283 74.59 1085 72.58
0.21
807 66.53
< 0.01
Yes 437 25.41 410 27.42 406 33.47
Delivery mode 1717 — 1495 — — 1213 — —
Vaginal 1361 79.27 1170 78.26
0.51
901 74.28
< 0.01
Caesarean 356 20.73 325 21.74 312 25.72
Gestational age 1722 — 1495 — — 1213 — —
22 weeks 204 11.85 165 11.04
0.90
19 1.57
< 0.01
23 weeks 281 16.32 252 16.86 139 11.46
24 weeks 366 21.25 322 21.54 303 24.98
25 weeks 436 25.32 391 26.15 374 30.83
26 weeks 435 25.26 365 24.41 378 31.16
Fetal sex 1719 — 1492 — — 1213 — —
Female 804 46.77 699 46.85
0.99
586 48.31
0.43
Male 915 53.23 793 53.15 627 51.69
HR>100 5 min after birth 1722 — 1495 — — 1213 — —
No 600 34.84 505 33.78
0.55
274 22.59
< 0.01
Yes 1122 65.16 990 66.22 939 77.41
Delivery room death 1722 — 1495 — — 1213 — —
No 1238 71.89 1078 72.11
0.92
1035 85.33
< 0.01
Yes 484 28.11 417 27.89 178 14.67
Counselled by... 1722 — 1495 — — 1213 — —
No one/not counselled 227 13.18 0 0.00
< 0.01
87 7.17
< 0.01
Junior obstetrician only 168 9.76 168 11.24 94 7.75
Senior obstetrician only 165 9.58 165 11.04 96 7.91
Paediatrician and junior obstetrician 418 24.27 418 27.96 353 29.10
Paediatrician and senior obstetrician 744 43.21 744 49.77 583 48.06
Decision to not perform C/S 1158 — 1017 — — 820 — —
No 807 69.69 666 65.49
0.04
571 69.63
1.00
Yes 351 30.31 351 34.51 249 30.37
Resuscitation choice expressed 1235 — 1130 — — 881 — —
No choice expressed 508 41.13 403 35.66
0.06
332 37.68
< 0.01
Full intensive care 391 31.66 391 34.60 346 39.27
Withhold intensive care 45 3.64 45 3.98 9 1.02
At paediatric discretion 291 23.56 291 25.75 194 22.02
Discussion about withholding care 1178 — 1048 — — 816 — —
Not discussed 713 60.53 583 55.63
0.02
545 66.79
0.01
Discussed 465 39.47 465 44.37 271 33.21
Characteristics of key variables from the EPICure 2 cohort study of births at 22–26 completed weeks of gestation in England in 2005. Mother-baby pairs were divided into
three populations: the full population consisted of babies who were alive at admission to hospital and the commencement of labour monitoring or the decision to perform
caesarean section (C/S). The two sub-populations studied in sensitivity analyses comprised mothers who received counselling, and those who received steroids
aChi-squared test comparing distributions in the “counselled” and “full” populations
bChi-squared test comparing distributions in the “steroids only” and “full” populations
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Table 2 The effect of antenatal steroids on condition at birth
Partial course Full course
P-valuea
N Effect (95 % CI) Effect (95 % CI)
Confounding only models
Baseline 1701 5.08 (3.84 – 6.72) 7.24 (5.60 – 9.36) —
Baseline + GA 1701 2.09 (1.51 – 2.90) 2.53 (1.85 – 3.45) < 0.001
’Clinical’ modelb 1602 1.42 (0.99 – 2.05) 1.64 (1.14 – 2.36) 0.013
Complete modelc 1602 1.38 (0.93 – 2.03) 1.82 (1.22 – 2.71) < 0.001
Models with effect modification by mode of deliveryb, c
Clinical model: Vaginal delivery
1602
1.61 (1.09 – 2.37) 1.66 (1.13 – 2.44)
0.018
Clinical model: Caesarean delivery 1.31 (0.46 – 3.69) 0.48 (0.17 – 1.39)
Complete model: vaginal delivery 1.84 (1.20 – 2.82) 1.63 (1.08 – 2.47)
0.021
Complete model: Caesarean delivery 1.23 (0.42 – 3.61) 0.42 (0.14 – 1.26)
Odds ratios of the effect of antenatal steroids on the presence of a heart rate greater than 100 at minutes of age in the complete population of babies born at 22–26 completed
weeks of gestation in England in 2006 who were known to be alive at admission to hospital and at the start of labour monitoring or delivery to perform Caesarean section
aLikelihood ratio test p-value, comparing current to next simplest model described
bThe clinical model for condition at birth was adjusted for: gestational age, tocolysis, mode of delivery, NICU level at birth, in utero transfer, presentation at delivery
cThe complete models were adjusted for the same factors as the clinical models, plus: who the parents were counselled by, what choice was expressed for resuscitation, and
whether a decision was made to not perform Caesarean section in the presence of fetal distress
Table 2. In contrast, the OR for those born after a com-
plete course of steroids decreased slightly from 1.66 (95%
CI: 1.13 – 2.44) to 1.63 (95% CI: 1.08 – 2.47). These find-
ings were reflected for delivery room death; full results are
in Table 3.
Sensitivity analysis
We repeated the analyses in the population who received
counselling. Potential confounders were the same as for
the primary analysis except the presence or absence of
labour had no effect when condition at birth was the
outcome, and level of neonatal unit at birth had no effect
of steroids on either outcome. Gestational age remained
the biggest confounding factor, with no evidence of dif-
fering effects by gestational age (LRT p = 0.44 for con-
dition at birth and p = 0.46 for delivery room death). As
for the primary analysis, there was evidence of interac-
tion with mode of delivery, with no effect seen in those
born by Caesarean section, but marked effects seen in
babies born vaginally for both partial and full courses of
steroids; full results are presented in Additional file 2:
Table S2.
Table 3 The effect of antenatal steroids on delivery room death
Partial course Full course
P-valuea
N Effect (95% CI) Effect (95% CI)
Confounding only models
Baseline 1701 0.13 (0.10 – 0.18) 0.09 (0.07 – 0.12) —
Baseline + GA 1701 0.39 (0.27 – 0.56) 0.35 (0.25 – 0.50) < 0.001
’Clinical’ modelb 1656 0.47 (0.32 – 0.70) 0.45 (0.30 – 0.67) 0.215
Complete modelc 1656 0.47 (0.31 – 0.74) 0.37 0.23 – 0.58) < 0.001
Models with effect modification by mode of deliveryb, c
Clinical model: vaginal delivery
1656
0.44 (0.29 – 0.67) 0.42 (0.28 – 0.63)
0.10
Clinical model: caesarean delivery 0.72 (0.21 – 2.50) 1.63 (0.44 – 6.09)
Complete model: vaginal delivery 0.34 (0.21 – 0.55) 0.41 (0.26 – 0.64)
0.083
Complete model: caesarean delivery 0.93 (0.24 – 3.63) 2.06 (0.49 – 8.65)
Odds ratios of the effect of antenatal steroids on delivery room death in the complete population of babies born at 22–26 completed weeks of gestation in England in 2006
who were known to be alive at admission to hospital and at the start of labour monitoring or delivery to perform Caesarean section
aLikelihood ratio test p-value, comparing current to next simplest model described
bThe clinical model for delivery room death was adjusted for: gestational age, tocolysis, mode of delivery, NICU level at birth, in utero transfer, and presence of a spontaneous
labour
cThe complete models were adjusted for the same factors as the clinical models, plus: who the parents were counselled by, what choice was expressed for resuscitation, and
whether a decision was made to not perform Caesarean section in the presence of fetal distress
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Tocolysis
Women who were treated with tocolytics (n = 437) dur-
ing the study period predominantly received atosiban
(n = 143, 32.7%) or nifedipine (n = 189, 43.3%). Other
drugs were given to 53 women (12.1%), 40 (9.2%) received
multiple drugs, and 12 women (2.7%) were recorded
as having tocolysis without the type of tocolytic being
recorded. As the study was not powered to examine indi-
vidual tocolytic drug effects, subjects were re-classified
as either having received tocolysis or not. Overall, tocol-
ysis was associated with a more frequent good outcome
(unadjusted OR 2.25, 95% CI: 1.75 – 2.90).
Univariate analysis identified gestational age, antenatal
steroids, neonatal care level available at birth, in utero
transfer, labour type and placental abruption as poten-
tial clinical confounders of the relationships with both
outcomes. Of the listed factors, all except labour type
had an important confounding effect between the use of
tocolysis and condition at birth, reducing the odds ratios
to 1.37 (95% CI: 1.01 – 1.87). After adding in variables
representing who provided counselling (if any was pro-
vided), parental choice regarding neonatal resuscitation,
and decision to not perform Caesarean section for fetal
distress, the odds ratio was 1.45 (95% CI: 1.05 – 2.00).
The inclusion of whether or not withholding care was
discussed did not affect the model, nor was there any evi-
dence of effect modification by any variable. The findings
for delivery room death were very similar, with the final
model including identical variables and demonstrating an
effect by tocolysis of 0.48 (95% CI: 0.32 – 0.73). Results are
shown in Table 4.
Sensitivity analysis
The effect of tocolysis was also studied in the popula-
tion of babies whose mothers received steroids. The same
factors plus the presence of maternal pre-eclampsia were
considered as potential confounders. Neither partial nor
full courses of antenatal steroids, in utero transfer or
labour type modified the effect of tocolysis on condition
at birth, with the clinical model showing an odds ratio
of 1.42 (95% CI: 1.04 – 1.96) and the complete model
an OR of 1.47 (95% CI: 1.06 – 2.04). For delivery room
death, gestational age and placental abruption were the
only clinical factors identified as playing an important
confounding role, leading to an adjusted OR of 0.49 (95%
CI: 0.32 – 0.73). Of the counselling factors, all except
whether withholding care was discussed made an impor-
tant contribution to the final model (OR 0.44 (95%CI: 0.28
– 0.67)); there was no evidence of interaction. Results are
tabulated alongside the complete population in Table 4.
Mode of delivery
Gestational age was the strongest factor confounding the
relationship between Caesarean section and both out-
comes, changing the OR for condition at birth from 4.21
(95% CI: 3.06 – 5.80) to 1.63 (95% CI: 1.15 – 2.33), and
for delivery room death from 0.16 (95% CI: 0.11 – 0.24)
to 0.67 (95% CI: 0.42 – 1.05). However, there was impor-
tant evidence of effect modification (likelihood ratio test
p = 0.017 for the relationship with condition at birth and
p = 0.016 for that with delivery room death) by week of
gestational age. Because very few Caesarean sections were
performed at low gestational ages (1, 6 and 42 at 22, 23 and
Table 4 Tocolysis regression results
Model
Complete population Steroids-only population
N OR 95% CI P-valuea N OR 95% CI P-valuea
Condition at birth
Baseline 1720 2.25 (1.75 – 2.90) < 0.0001 1213 1.44 (1.08 – 1.95) 0.0138
Baseline + GAb 1720 1.64 (1.24 – 2.18) < 0.0001 1213 1.53 (1.12 – 2.09) < 0.0001
Clinicalc 1655 1.37 (1.01 – 1.87) < 0.0001 1205 1.42 (1.04 – 1.96) < 0.0001
Counsellingd 1655 1.45 (1.05 – 2.00) < 0.0001 1205 1.47 (1.06 – 2.04) < 0.0001
Delivery Room death
Baseline 1720 0.33 (0.24 – 0.44) < 0.0001 1213 0.53 (0.36 – 0.76) 0.0005
Baseline + GAb 1720 0.46 (0.32 – 0.65) < 0.0001 1213 0.47 (0.31 – 0.70) < 0.0001
Clinicalc 1655 0.58 (0.39 – 0.84) < 0.0001 1211 0.49 (0.32 – 0.73) < 0.0001
Counsellingd 1655 0.48 (0.32 – 0.73) < 0.0001 1211 0.43 (0.28 – 0.66) < 0.0001
Odds ratios of the effect of tocolysis on the presence of a heart rate greater than 100 at minutes of age or to delivery room death in the complete population of babies born
at 22–26 completed weeks of gestation in England in 2006 who were known to be alive at admission to hospital and at the start of labour monitoring or delivery to perform
Caesarean section, and the restricted population of those babies born to women who received antenatal steroids
aLikelihood ratio test p-value comparing model against next simplest model
bGA: gestational age
cThe clinical models for condition at birth and delivery room death were adjusted for: provision of antenatal steroids, NICU level at birth, in utero transfer and presence of
placental abruption
dIn addition to the factors adjusted for in the clinical models, the complete models were also adjusted for who counselling was provided by, whether and what choice was
expressed for resuscitation, and whether a decision was made to not perform Caesarean section in the presence of fetal distress
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24 weeks gestation, respectively), we collapsed the 22–24
week categories into a single group. Caesarean delivery
was then associated with birth in a good condition at ≤24
and 25 weeks (ORs 3.89 (95% CI: 2.00 – 7.58) and 1.85
(95% CI: 1.02 – 3.34)), but not at 26 weeks gestation (0R
1.22, 95% CI: 0.69 – 2.18). For delivery room death, a dif-
ference was only shown for those born at 24 weeks or
below (0.24, 95% CI: 0.12 – 0.50), with no association at
either 25 or 26 weeks (0.79, 95% CI: 0.39 – 1.63, and 0.63,
95% CI: 0.24 – 1.70, respectively).
A further consideration is the presence or not of labour:
only 64 women underwent Caesarean section following
spontaneous onset of labour, compared with 292 who
were not in labour. Including this removed the associa-
tion with condition at birth for women in spontaneous
labour, but demonstrated a strong association in women
who were not in labour at both 24 weeks and below (OR
13.5, 95% CI: 3.50 – 52.08), and 25 weeks (4.13, 95% CI:
1.35 – 12.62). These findings were little changed after the
addition of the remaining clinical variables (Table 5) There
were similar findings for delivery room death, with no
evidence of an effect from Caesarean delivery after spon-
taneous labour and marked evidence for babies born to
women not in labour at ≤ 24 and 25 weeks, but no effect
for those born at 26 weeks (Table 5).
Sensitivity analysis
In the steroids-only population, there was strong evidence
for both outcomes of effect modification by labour type,
but gestational age only acted as a confounder. For condi-
tion at birth as the outcome, in utero transfer, presentation
at delivery, the level of neonatal care available at the birth
hospital, maternal pre-eclampsia and placental abruption
were also identified as confounders, leading to adjusted
ORs of 8.67 (95% CI: 3.47 – 21.70) and 1.22 (95% CI: 0.71
– 2.09) for women who were not in labour and those in
spontaneous labour, respectively. In the model including
counselling, who the subject was counselled by, whether
a decision was made not to perform Caesarean section
in the presence of fetal distress, and whether or not a
choice was expressed about resuscitation all had impor-
tant effects, resulting in an OR for women not in labour
of 5.55 (95% CI: 2.13 – 14.47) whereas for women in
labour there was no evidence of an effect (Additional file 2:
Table S3).
In addition to gestational age and labour type, con-
founders of the effect of Caesarean delivery on delivery
room death were the length of course of antenatal steroids
(partial or full), in utero transfer, presentation at delivery,
maternal pre-eclampsia and placental abruption. Inclu-
sion of these reduced the odds of dying for babies born to
Table 5 Delivery regression results
Model N
≤24 weeks 25 weeks 26 weeks
P-valuea
OR (95% CI) OR (95% CI) OR (95% CI)
Condition at birth
Baseline 1717 3.89 (2.00 – 7.58) 1.85 (1.02 – 3.34) 1.22 (0.69 – 2.18) 0.031
Baseline: no labour
1712
13.5 (3.50 – 52.08) 4.13 (1.35 – 12.62) 0.98 (0.11 – 8.41)
0.018
Baseline: spontaneous labour 1.79 (0.76 – 4.24) 1.95 (0.79 – 4.79) 0.75 (0.35 – 1.58)
Clinical: no labourb
1680
22.96 (5.19 – 101.52) 8.24 (2.49 – 27.33) 2.22 (0.24 – 20.16)
0.001
Clinical: spontaneous labourb 1.18 (0.47 – 2.96) 2.01 (0.80 – 5.08) 0.71 (0.33 – 1.54)
Complete: no labourc
1680
12.67 (2.79 – 57.60) 4.94 (1.44 – 16.90) 1.56 (0.16 – 14.81)
< 0.001
Complete: spontaneous labourc 0.95 (0.38 – 2.40) 1.58 (0.62 – 4.03) 0.70 (0.32 – 1.52)
Delivery room death
Baseline 1717 0.24 (0.12 – 0.50) 0.79 (0.39 – 1.63) 0.63 (0.24 – 1.70) 0.055
Baseline: no labour
1712
0.05 (0.01 – 0.23) 0.20 (0.06 – 0.67) 0.39 (0.04 – 3.76)
0.019
Baseline: spontaneous labour 0.56 (0.23 – 1.35) 0.82 (0.27 – 2.44) 0.65 (0.14 – 2.97)
Clinical: no labourb
1680
0.01 (0.00 – 0.09) 0.06 (0.02 – 0.25) 0.09 (0.01 – 1.03)
< 0.001
Clinical: spontaneous labourb 0.96 (0.36 – 2.55) 0.77 (0.25 – 2.43) 0.63 (0.13 – 3.00)
Complete: no labourc
1680
0.03 (0.01 – 0.21) 0.13 (0.03 – 0.55) 0.12 (0.01 – 1.63)
< 0.001
Complete: spontaneous labourc 1.36 (0.50 – 3.70) 1.07 (0.33 – 3.46) 0.63 (0.13 – 3.00)
Odds ratios of the effect of delivery by caesaerean section on the presence of a heart rate greater than 100 at minutes of age or to delivery room death in the complete
population of babies born at 22–26 completed weeks of gestation in England in 2006 who were known to be alive at admission to hospital and at the start of labour
monitoring or delivery to perform Caesarean section
aLikelihood ratio test comparing model against next simplest model
bThe clinical models were additionally adjusted for: antenatal steroids, in utero transfer, maternal pre-eclampsia and placental abruption
cThe complete models were adjusted for the same factors as the clinical models, plus: who the parents were counselled by, whether a decision was made not to perform
Caesarean section in cases of fetal distress, what choice was expressed for resuscitation, and whether withholding care was discussed
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women not in labour to 0.05 (95% CI: 0.02 – 0.17), with
no effect in women who were in spontaneous labour (OR
0.90, 95% CI: 0.45 – 1.81). There was little change fol-
lowing the inclusion of all counselling variable (Additional
file 2: Table S3).
Discussion
Principal findings
This study produced strong evidence that antenatal
steroids are associated with improved survival at birth as
well as with being born in better condition for singletons
born at 22 to 26+6 weeks gestation. These results were
obtained even after accounting for potential decision-
making influences, and particularly in those babies born
vaginally. Tocolysis was also associated with improve-
ments in both outcomes. In contrast, mode of delivery was
subject to effect modification by gestational age and by the
presence or not of spontaneous labour. There was no evi-
dence of an effect by Caesarean section at any gestation
in women with spontaneous labour, but in women with-
out spontaneous labour there were bigger effects at lower
gestations. This finding was even more pronounced for
the outcome of delivery room death than for condition at
birth.
Strengths and limitations of this study
Our study benefits from the size and the completeness of
the data that were available: it covers the entire population
of England, and data collection was comprehensive [2].
It was therefore possible to obtain robust statistical evi-
dence in support of results. This provides a high degree of
certainty about how the usage of antenatal steroids, tocol-
ysis and operative delivery affected immediate outcomes
for these extremely premature babies in 2006 in England.
However, many of the regression analyses were com-
plex, particularly when considering interaction, resulting
in small numbers within individual cells and an increased
possibility of error. This is reflected by wide confidence
intervals in results – particularly evident in the mode of
delivery analyses.
Non-reporting, selection bias may have arisen due to
small numbers of missing data points. However, this
would tend to weaken the effects reported. For exam-
ple, missing data were most common in the gestation at
which mother booked for care; no differences were seen
in reported data comparing late versus early booking,
however, it is equally plausible that there was no effect
anyway.
More importantly, the counselling variables were
incompletely filled out. We therefore based analyses on
whether there was evidence that counselling was carried
out or not. This may have led to us underestimating the
confounding impact of these variables if there was under-
recording of positive responses; we think it is more likely
that positive responses will have been recorded, and that
in those subjects where a response was missing the rel-
evant conversation is less likely to have occurred. The
incomplete counselling variables may particularly have
affected the sensitivity analyses for the effect of antena-
tal steroids. In actual fact, the point estimates obtained
from the sensitivity analyses are more biologically plausi-
ble than the main analyses as a dose-response relationship
is seen in all models. Reassuringly, effect magnitudes and
confidence intervals are similar across both sets of analy-
ses (using the main and counselled populations).
Recall bias was minimised as data were collected con-
temporaneously, but there may have been differential
reporting at the various study centres leading to differ-
ential misclassification. Clear instructions were provided
with the initial data collection form in order to prevent
this, and the data are internally consistent [2]. Thus, this is
likely to have had little if any impact on the results. Within
the statistical analyses, a conservative attitude was taken
in interpreting ambiguous data; this meant that interpre-
tation was restricted on occasion. For example, chorioam-
nionitis is a diverse condition that is poorly diagnosed on
both clinical and histological grounds [7]. Because of the
wording of the questions that had been used, the analysis
was only able to look at the combined group of “clinical
suspicion of chorioamnionitis at any time before birth”
and those in whom “chorioamnionitis [was] noted at time
of birth”, rather than more precise patient categories. Any
misclassification that resulted from this would have hap-
pened in a non-differential fashion, and therefore be likely
to bias results towards the null.
Somemay argue our choices of confounding variables in
the analyses are wrong; particularly, in the steroids anal-
ysis, the inclusion of mode of delivery as a covariate may
appear bizarre, as it seems to be on the causal pathway,
as shown when considering Additional file 1: Figures S3
and S4 together. However, mode of delivery may instead
be considered as a marker for intention to deliver – for,
having made a decision to delivery operatively (e.g. in the
presence of intrauterine growth retardation), one would
first ensure that steroids had been administered; in this
scenario, the model then makes sense.
Our results may, however, be impacted by residual
confounding. More detail could have been obtained
about the current variables: for instance, we have lit-
tle detail regarding tocolysis – how long women were
administered drugs for, or at which doses. However, we
believe we have captured the most important variables:
this is demonstrated through confounding by gesta-
tional age and the use of antenatal steroids, which had
consistently large impacts throughout all analyses. Fur-
thermore, a longer study period or a larger baseline
population would be required to power more detailed
investigations.
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More specifically, residual confounding may have
occurred in relation to the counselling information. The
low completion rates for these variables in comparison
to other questions, together with the patterns of over-
lap in the responses, suggests there was some confusion
in answering these questions. This raises the possibility
that the true confounding effects of perinatal decision-
making at the borders of viability have not been accounted
for. However, when analyses excluding counselling vari-
ables (“clinical” models in Tables 2, 3, 4 and 5 and
Additional file 2: Tables S2 and S3) are compared with
those that include them (the “complete” models), there
tended to be a more pronounced effect in the complete
(i.e. including counselling factors) models. We also find
reassurance in our results by recognising that effects
are in the direction and of a magnitude that might be
expected.
Study findings in context
There are very marked improvements in survival and con-
dition at birth in babies born via operative delivery at low
gestations to women who were not in labour, while no
benefit is seen from performing Caesarean sections for
women who are already in labour. This suggests that there
is an important influence from case selection: very few
Caesarean sections were performed at the lowest gesta-
tions (1, 6 and 42 at 22, 23 and 24 weeks respectively)
where the odds of a favourable outcome are the high-
est. At these gestations, Caesarean section will only be
offered to women who are not in labour if the fetus is
considered viable, thus making these findings difficult to
interpret.
Our findings are compatible with a Cochrane Review
investigating the effect of Caesarean delivery in prema-
ture singleton babies that found no evidence of a dif-
ference in mortality [8]. However, the review identified
only six studies, three of which examined mortality, and
only two of these including births as low as 26 weeks
gestational age [8]. Our results are also compatible with
another study using registry data from the United States
[9]. That study used a “trimming procedure” to ensure that
only births with congruent birth weight and gestational
age data were included. Neonatal mortality was lower
in babies born operatively at 25 weeks and below, with
more pronounced differences with decreasing gestational
age [9].
Tocolysis was associated with an improved outcome in
all groups, even after accounting for antenatal steroids,
gestational age, perinatal counselling and other factors.
These data therefore suggest that therapy is appro-
priately targeted by current obstetric practice within
the population of women who present with threatened
extremely preterm labour. There are a plethora of stud-
ies and systematic reviews relating to specific questions
about tocolysis – for instance, a recent network meta-
analysis identified 95 randomised controlled trials com-
paring tocolytics with either each other or placebo, [10]
and observed that no single tocolytic drug was asso-
ciated with improved neonatal mortality or decreased
morbidity. However, there were no data presented on
the effect of gestational age in any of the analyses
[10] and very few data evaluate the impact of tocoly-
sis on neonatal mortality at extremely low gestational
ages [11, 12].
Perhaps most notably, in independent analysis, antena-
tal steroids were consistently associated with improved
outcomes; they were also among the strongest con-
founders for the other exposures. This is worth highlight-
ing as, while the results are similar to other studies that
have looked at longer term survival [13–16] or shorter
term outcomes in the population of babies admitted
into neonatal intensive care, [16] there is little biolog-
ical reason apparent for steroids to cause an improve-
ment in condition at birth or survival in the delivery
room.
An alternative possibility is that steroids may simply be
a marker of other reasons for the improved survival rate.
This fact would warrant further investigation if we had
not adjusted for prior intention (by both parents and clin-
ical teams) through the use of data related to perinatal
counselling. Despite our questions being crude, we are
confident that they captured an important aspect of the
management as, with the exception of whether withhold-
ing care was discussed or not, all counselling variables
made important contributions towards the final models
in all analyses. While a future study could investigate
this further by including more – and more detailed –
questions specifically related to the intention to resusci-
tate and provision of further care, difficulty remains in
ensuring adequate response rates. Consequently, if our
findings are true, there is a biological effect from the
administration of antenatal steroids that improves short-
term survival – an effect that is particularly marked in
those born by vaginal delivery. This warrants further
study.
Conclusion
In conclusion, we have demonstrated the effect of ante-
natal steroids, tocolysis and mode of delivery on the
chances of being born in a good condition and of
delivery-room death for babies delivered at 26 completed
weeks gestational age or below in England using data
from a 2006 birth cohort. The results demonstrate the
importance of antenatal steroids in determining early
condition of babies born vaginally, and provide esti-
mates of the impact of tocolysis and Caesarean section
that may be used when counselling patients and their
families.
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